Roper Technologies (ROP) Q4 2025 earnings review
Compounding Continues, Though Organic Growth Cools
Roper delivered a solid Q4 with 10% total revenue growth and continued margin expansion, capping a year where they deployed $3.3 billion into M&A. However, organic growth decelerated to 4% in Q4 (down from 6% in Q3 and 7% in Q2), marking the lowest point of the fiscal year. While Adjusted EBITDA grew 10%, GAAP Net Income fell 7% due to rising interest expenses and amortization. Management initiated FY26 guidance calling for ~8% total revenue growth and 5-6% organic growth, suggesting a stable but slightly decelerating topline trajectory compared to FY25.
🐂 Bull Case
Roper deployed $3.3B in M&A during FY25 and initiated a share buyback program, repurchasing $500M in stock in Q4. The dual engine of M&A and buybacks demonstrates strong cash flow conversion and capital discipline.
The Network Software segment remains a standout, growing revenue 14% YoY in Q4 with a robust 42.6% operating margin, significantly outpacing other segments.
🐻 Bear Case
Organic revenue growth slowed sequentially throughout the year, ending at 4% in Q4. This raises questions about underlying demand across the portfolio, particularly given the 6-7% target ranges often cited in the past.
Rising interest expenses ($93M in Q4 vs $71M prior year) and increased amortization are pressuring GAAP earnings. GAAP DEPS fell 7% YoY, diverging significantly from the 8% growth in Adjusted DEPS.
⚖️ Verdict: ⚪
Neutral. While the cash flow compounding thesis remains intact, the deceleration in organic growth to 4% requires monitoring. The initiation of guidance at 5-6% organic for 2026 is constructive, but the Q4 exit velocity was soft.
Key Themes
Organic Growth Deceleration
Decelerating. Organic growth stepped down to 4% in Q4, compared to 6% in Q3 and 7% in Q2. While FY26 guidance projects a rebound to 5-6%, the Q4 dip suggests softening demand or delayed deal closures in key verticals at year-end.
Buyback Program Activation
For the first time in recent history, Roper utilized its share repurchase program meaningfully, buying back 1.12 million shares for $500 million in Q4. This signals management conviction in the valuation and adds a new lever for EPS growth alongside M&A.
Interest Expense Drag
Accelerating Costs. Interest expense jumped 31% YoY in Q4 ($93M vs $71M) and 25% for the full year ($325M vs $259M). This rising cost of capital is actively suppressing GAAP net earnings, causing a 7% decline in GAAP Net Income despite 10% topline growth.
Network Software Outperformance
Stable/High Performance. The Network Software segment continues to carry the portfolio's margin profile. In Q4, it delivered 42.6% operating margins (vs 26.6% for App Software and 33.5% for TEP) while growing revenue 14%.
AI & Innovation Focus
Management explicitly cited 'meaningful enhancements' to AI technical capabilities in 2025 as a foundation for 2026. This focus on commercializing AI across the vertical software portfolio is expected to fuel the long-term growth algorithm, though immediate financial impact remains qualitative.
Other KPIs
Stable. Up 4% YoY. While positive, FCF growth lagged Adjusted Net Earnings growth (8%) and Revenue growth (10%). For the full year, FCF margins remained robust, but conversion in Q4 was slightly softer than the topline expansion suggests.
Stable. Essentially flat (+10 bps YoY). The company maintained its high-margin profile despite integrating recent acquisitions, which typically carry initially lower margins before synergy realization.
Decelerating. Growth was 10% YoY, but this compares to roughly 19% growth seen in 25Q1 and 25Q2 (driven by acquisitions). As acquisitions lap, the segment is settling into a lower growth tier.
Guidance
Decelerating. The midpoint ($21.425) implies ~7.1% growth over FY25's $20.00. This is slower than the 9% growth achieved in FY25, reflecting a more conservative outlook on organic expansion and interest headwinds.
Decelerating. Down from 12% realized in FY25. This reflects a smaller contribution from carryover M&A compared to the prior year, placing more burden on organic execution.
Accelerating vs Q4. This range implies an acceleration from the 4% exit rate seen in Q4 2025. It aligns with Roper's long-term historical targets but suggests Q4 2025 was a trough.
Decelerating. The midpoint implies a decline from Q4 2025's $5.21 (seasonal) and roughly 4% YoY growth vs 25Q1 ($4.78). This is a slow start to the year compared to the full-year target of ~7% growth.
Key Questions
Organic Growth Exit Rate
Organic growth slowed sequentially to 4% in Q4. Can you decompose this deceleration? Was it driven by specific delays in GovCon (Deltek) or broader macro softness in the Network segment?
GAAP vs. Adjusted Divergence
GAAP Net Earnings declined 7% while Adjusted Earnings grew 8%. With interest expenses rising significantly, at what point do you expect the GAAP earnings trajectory to realign with the Adjusted figures?
Buyback Strategy Shift
You repurchased $500M in shares in Q4, a significant deviation from your usual M&A-first capital allocation. Does this signal a lack of attractively priced M&A targets, or is it a structural shift to a balanced capital return model?
2026 Organic Assumptions
Guidance calls for 5-6% organic growth in 2026, implying an acceleration from Q4's 4%. What gives you confidence in this re-acceleration given the slow start guided for Q1 ($4.95-$5.00 DEPS)?